Stock Events

Bayer 

€26.08
4000
-€0.31-1.16% Today

Statistics

Day High
26.49
Day Low
25.98
52W High
67.5
52W Low
43.9
Volume
73,238.14
Avg. Volume
979,285
Mkt Cap
51.7B
P/E Ratio
-
Dividend Yield
0.41%
Dividend
0.11

Upcoming

Dividends

0.41%Dividend Yield
10Y Growth
-16.64%
5Y Growth
-48.11%
3Y Growth
-63.51%
1Y Growth
-95.54%

Earnings

5NovExpected
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
Q2 2024
Next
0.38
1.24
2.09
2.95
Expected EPS
0.43094990302182723
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 0P6S.LSE. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines for self-medication and self-care; and solutions for nutritional supplements, allergy, cough and cold, dermatology, pain and cardiovascular risk prevention, and digestive health. This segment also provides breeding, propagation, and production/processing of seeds, including seed dressing. The company has a collaboration with Acuitas Therapeutics, Inc. to strengthen gene editing programs; Peking University in the area of basic pharmaceutical research; the Swiss Tropical and Public Health Institute in the development of the compound emodepside for the treatment of infection with soil-transmitted helminths; bit.bio Ltd. for the discovery and manufacture of regulatory T cells for use in creating therapeutics; Hologic, Inc. in the field of contrastenhanced-mammography solutions to improve diagnostic imaging for the detection of breast cancer; and Twist Bioscience Corporation centering around the research and development of antibody-based pharmaceuticals, as well as with CrossBay Medical Inc. It distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. The company has collaboration with Thermo Fisher Scientific. Bayer Aktiengesellschaft was founded in 1863 and is based in Leverkusen, Germany.
Show more...
CEO
Mr. William N. Anderson
Employees
96567
Country
DE
ISIN
DE000BAY0017

Listings